Cargando…

Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection

Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveill...

Descripción completa

Detalles Bibliográficos
Autores principales: Savela, Emily S., Winnett, Alexander, Romano, Anna E., Porter, Michael K., Shelby, Natasha, Akana, Reid, Ji, Jenny, Cooper, Matthew M., Schlenker, Noah W., Reyes, Jessica A., Carter, Alyssa M., Barlow, Jacob T., Tognazzini, Colten, Feaster, Matthew, Goh, Ying-Ying, Ismagilov, Rustem F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043477/
https://www.ncbi.nlm.nih.gov/pubmed/33851180
http://dx.doi.org/10.1101/2021.04.02.21254771
_version_ 1783678312544993280
author Savela, Emily S.
Winnett, Alexander
Romano, Anna E.
Porter, Michael K.
Shelby, Natasha
Akana, Reid
Ji, Jenny
Cooper, Matthew M.
Schlenker, Noah W.
Reyes, Jessica A.
Carter, Alyssa M.
Barlow, Jacob T.
Tognazzini, Colten
Feaster, Matthew
Goh, Ying-Ying
Ismagilov, Rustem F.
author_facet Savela, Emily S.
Winnett, Alexander
Romano, Anna E.
Porter, Michael K.
Shelby, Natasha
Akana, Reid
Ji, Jenny
Cooper, Matthew M.
Schlenker, Noah W.
Reyes, Jessica A.
Carter, Alyssa M.
Barlow, Jacob T.
Tognazzini, Colten
Feaster, Matthew
Goh, Ying-Ying
Ismagilov, Rustem F.
author_sort Savela, Emily S.
collection PubMed
description Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveillance and symptomatic testing, but the ability of low-sensitivity nasal-swab tests to detect the earliest stages of infection has not been established. In this case-ascertained study, initially-SARS-CoV-2-negative household contacts of individuals diagnosed with COVID-19 prospectively self-collected paired anterior-nares nasal-swab and saliva samples twice daily for viral-load quantification by high-sensitivity RT-qPCR and digital-RT-PCR assays. We captured viral-load profiles from the incidence of infection for seven individuals and compared diagnostic sensitivities between respiratory sites. Among unvaccinated persons, high-sensitivity saliva testing detected infection up to 4.5 days before viral loads in nasal swabs reached the limit of detection of low-sensitivity nasal-swab tests. For most participants, nasal swabs reached higher peak viral loads than saliva, but were undetectable or at lower loads during the first few days of infection. High-sensitivity saliva testing was most reliable for earliest detection. Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections. Such data are challenging to acquire but critical to design optimal testing strategies in the current pandemic and will be required for responding to future viral pandemics. As new variants and viruses emerge, up-to-date data on viral kinetics are necessary to adjust testing strategies for reliable early detection of infections.
format Online
Article
Text
id pubmed-8043477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-80434772021-04-14 Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection Savela, Emily S. Winnett, Alexander Romano, Anna E. Porter, Michael K. Shelby, Natasha Akana, Reid Ji, Jenny Cooper, Matthew M. Schlenker, Noah W. Reyes, Jessica A. Carter, Alyssa M. Barlow, Jacob T. Tognazzini, Colten Feaster, Matthew Goh, Ying-Ying Ismagilov, Rustem F. medRxiv Article Early detection of SARS-CoV-2 infection is critical to reduce asymptomatic and pre-symptomatic transmission, curb the spread of variants by travelers, and maximize treatment efficacy. Low-sensitivity nasal-swab testing (antigen and some nucleic-acid-amplification tests) is commonly used for surveillance and symptomatic testing, but the ability of low-sensitivity nasal-swab tests to detect the earliest stages of infection has not been established. In this case-ascertained study, initially-SARS-CoV-2-negative household contacts of individuals diagnosed with COVID-19 prospectively self-collected paired anterior-nares nasal-swab and saliva samples twice daily for viral-load quantification by high-sensitivity RT-qPCR and digital-RT-PCR assays. We captured viral-load profiles from the incidence of infection for seven individuals and compared diagnostic sensitivities between respiratory sites. Among unvaccinated persons, high-sensitivity saliva testing detected infection up to 4.5 days before viral loads in nasal swabs reached the limit of detection of low-sensitivity nasal-swab tests. For most participants, nasal swabs reached higher peak viral loads than saliva, but were undetectable or at lower loads during the first few days of infection. High-sensitivity saliva testing was most reliable for earliest detection. Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections. Such data are challenging to acquire but critical to design optimal testing strategies in the current pandemic and will be required for responding to future viral pandemics. As new variants and viruses emerge, up-to-date data on viral kinetics are necessary to adjust testing strategies for reliable early detection of infections. Cold Spring Harbor Laboratory 2021-08-26 /pmc/articles/PMC8043477/ /pubmed/33851180 http://dx.doi.org/10.1101/2021.04.02.21254771 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Savela, Emily S.
Winnett, Alexander
Romano, Anna E.
Porter, Michael K.
Shelby, Natasha
Akana, Reid
Ji, Jenny
Cooper, Matthew M.
Schlenker, Noah W.
Reyes, Jessica A.
Carter, Alyssa M.
Barlow, Jacob T.
Tognazzini, Colten
Feaster, Matthew
Goh, Ying-Ying
Ismagilov, Rustem F.
Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title_full Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title_fullStr Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title_full_unstemmed Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title_short Quantitative SARS-CoV-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
title_sort quantitative sars-cov-2 viral-load curves in paired saliva and nasal swabs inform appropriate respiratory sampling site and analytical test sensitivity required for earliest viral detection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043477/
https://www.ncbi.nlm.nih.gov/pubmed/33851180
http://dx.doi.org/10.1101/2021.04.02.21254771
work_keys_str_mv AT savelaemilys quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT winnettalexander quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT romanoannae quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT portermichaelk quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT shelbynatasha quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT akanareid quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT jijenny quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT coopermatthewm quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT schlenkernoahw quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT reyesjessicaa quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT carteralyssam quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT barlowjacobt quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT tognazzinicolten quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT feastermatthew quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT gohyingying quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection
AT ismagilovrustemf quantitativesarscov2viralloadcurvesinpairedsalivaandnasalswabsinformappropriaterespiratorysamplingsiteandanalyticaltestsensitivityrequiredforearliestviraldetection